Author:
Srikantan V.,Srivastava S.
Publisher
Springer Berlin Heidelberg
Reference128 articles.
1. Apakama I, Robinson MC, Walter NM, Charlton RG, Royd JA, Fuller CE, Neal DE, Hamdy FC (1996) bcl-2 overexpression combined with p53 accumulation correlates with hormone refractory prostate cancer. Br J Cancer 74:1258–1262
2. Arai Y, Yoskiki T, Yoshida O (1997) c-erbB-2oncoprotein: a potential biomarker of advanced prostate cancer. Prostate 30:195–201
3. Asgari K, Sesterhenn IA, McLeod DG, Cowan K, Moul JW, Seth P, Srivastava S (1997) Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector. Int J Cancer 71:377–382
4. Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Moul JW. (1995) p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. Clin Cancer Res 1:1295–1300
5. Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Moul JW. (1996) Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer patients. J Urol 156:1511–1516
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献